LONDON—GlaxoSmithKline PLC on Tuesday named Emma Walmsley as chief executive officer designate to take over from Andrew Witty when he retires next year.

In March, the pharmaceutical giant said Mr. Witty would retire as chief executive in March 2017, after a career at the company spanning more than 30 years and almost 10 years as its chief executive.

Ms. Walmsley, who is currently chief executive officer of GlaxoSmithKline's Consumer Healthcare division, will join the company's board of directors from January 2017.

Ms. Walmsley joined GlaxoSmithKline in 2010 from L'Oré al.

The company said its remuneration policy is currently under review and the remuneration committee will begin consultations with shareholders in the fourth quarter of 2016.

Write to Razak Musah Baba at Razak.Baba@wsj.com

(END) Dow Jones Newswires

September 20, 2016 03:25 ET (07:25 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more GSK Charts.